nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—SCN5A—Riluzole—amyotrophic lateral sclerosis	0.74	1	CbGbCtD
Fosphenytoin—Diabetes insipidus—Riluzole—amyotrophic lateral sclerosis	0.0179	0.0693	CcSEcCtD
Fosphenytoin—Subdural haematoma—Riluzole—amyotrophic lateral sclerosis	0.00803	0.0312	CcSEcCtD
Fosphenytoin—Pneumonia aspiration—Riluzole—amyotrophic lateral sclerosis	0.00771	0.0299	CcSEcCtD
Fosphenytoin—Skin nodule—Riluzole—amyotrophic lateral sclerosis	0.00606	0.0235	CcSEcCtD
Fosphenytoin—Skin mass—Riluzole—amyotrophic lateral sclerosis	0.00543	0.0211	CcSEcCtD
Fosphenytoin—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00517	0.02	CcSEcCtD
Fosphenytoin—Hemiplegia—Riluzole—amyotrophic lateral sclerosis	0.00471	0.0183	CcSEcCtD
Fosphenytoin—Rectal tenesmus—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0175	CcSEcCtD
Fosphenytoin—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.00452	0.0175	CcSEcCtD
Fosphenytoin—Hypochromic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00434	0.0168	CcSEcCtD
Fosphenytoin—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0041	0.0159	CcSEcCtD
Fosphenytoin—Personality disorder—Riluzole—amyotrophic lateral sclerosis	0.00389	0.0151	CcSEcCtD
Fosphenytoin—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0139	CcSEcCtD
Fosphenytoin—Proctalgia—Riluzole—amyotrophic lateral sclerosis	0.00359	0.0139	CcSEcCtD
Fosphenytoin—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0131	CcSEcCtD
Fosphenytoin—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00338	0.0131	CcSEcCtD
Fosphenytoin—Vaginal moniliasis—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0129	CcSEcCtD
Fosphenytoin—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.00334	0.0129	CcSEcCtD
Fosphenytoin—Vulvovaginal candidiasis—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0124	CcSEcCtD
Fosphenytoin—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0032	0.0124	CcSEcCtD
Fosphenytoin—Anorectal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0119	CcSEcCtD
Fosphenytoin—Vulvovaginal mycotic infection—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0119	CcSEcCtD
Fosphenytoin—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0118	CcSEcCtD
Fosphenytoin—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0118	CcSEcCtD
Fosphenytoin—Generalised oedema—Riluzole—amyotrophic lateral sclerosis	0.00283	0.011	CcSEcCtD
Fosphenytoin—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0109	CcSEcCtD
Fosphenytoin—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00268	0.0104	CcSEcCtD
Fosphenytoin—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00967	CcSEcCtD
Fosphenytoin—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00245	0.00949	CcSEcCtD
Fosphenytoin—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00931	CcSEcCtD
Fosphenytoin—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00923	CcSEcCtD
Fosphenytoin—Ileus—Riluzole—amyotrophic lateral sclerosis	0.00238	0.00923	CcSEcCtD
Fosphenytoin—Methylphenobarbital—GRIA2—amyotrophic lateral sclerosis	0.0023	0.854	CrCbGaD
Fosphenytoin—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00227	0.00882	CcSEcCtD
Fosphenytoin—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00875	CcSEcCtD
Fosphenytoin—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00867	CcSEcCtD
Fosphenytoin—Amblyopia—Riluzole—amyotrophic lateral sclerosis	0.00218	0.00846	CcSEcCtD
Fosphenytoin—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00806	CcSEcCtD
Fosphenytoin—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00794	CcSEcCtD
Fosphenytoin—Apnoea—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0077	CcSEcCtD
Fosphenytoin—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00196	0.00759	CcSEcCtD
Fosphenytoin—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.0019	0.00738	CcSEcCtD
Fosphenytoin—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.00186	0.00723	CcSEcCtD
Fosphenytoin—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00713	CcSEcCtD
Fosphenytoin—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00713	CcSEcCtD
Fosphenytoin—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00695	CcSEcCtD
Fosphenytoin—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0069	CcSEcCtD
Fosphenytoin—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00665	CcSEcCtD
Fosphenytoin—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00653	CcSEcCtD
Fosphenytoin—Injection site reaction—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00649	CcSEcCtD
Fosphenytoin—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00166	0.00645	CcSEcCtD
Fosphenytoin—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00631	CcSEcCtD
Fosphenytoin—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00631	CcSEcCtD
Fosphenytoin—Fluid retention—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0062	CcSEcCtD
Fosphenytoin—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00158	0.00613	CcSEcCtD
Fosphenytoin—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00155	0.006	CcSEcCtD
Fosphenytoin—Coma—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00597	CcSEcCtD
Fosphenytoin—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0059	CcSEcCtD
Fosphenytoin—Sepsis—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00567	CcSEcCtD
Fosphenytoin—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00567	CcSEcCtD
Fosphenytoin—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00556	CcSEcCtD
Fosphenytoin—Ear pain—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00556	CcSEcCtD
Fosphenytoin—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0053	CcSEcCtD
Fosphenytoin—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00523	CcSEcCtD
Fosphenytoin—Injury—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00516	CcSEcCtD
Fosphenytoin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.0013	0.00505	CcSEcCtD
Fosphenytoin—Anaphylactoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0049	CcSEcCtD
Fosphenytoin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00474	CcSEcCtD
Fosphenytoin—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00474	CcSEcCtD
Fosphenytoin—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00474	CcSEcCtD
Fosphenytoin—Migraine—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00467	CcSEcCtD
Fosphenytoin—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.0012	0.00467	CcSEcCtD
Fosphenytoin—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00463	CcSEcCtD
Fosphenytoin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00458	CcSEcCtD
Fosphenytoin—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00451	CcSEcCtD
Fosphenytoin—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00451	CcSEcCtD
Fosphenytoin—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00449	CcSEcCtD
Fosphenytoin—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00115	0.00446	CcSEcCtD
Fosphenytoin—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00441	CcSEcCtD
Fosphenytoin—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00113	0.00438	CcSEcCtD
Fosphenytoin—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00433	CcSEcCtD
Fosphenytoin—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00431	CcSEcCtD
Fosphenytoin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0042	CcSEcCtD
Fosphenytoin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00418	CcSEcCtD
Fosphenytoin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0041	CcSEcCtD
Fosphenytoin—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0041	CcSEcCtD
Fosphenytoin—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00106	0.0041	CcSEcCtD
Fosphenytoin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00394	CcSEcCtD
Fosphenytoin—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000988	0.00383	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00374	CcSEcCtD
Fosphenytoin—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000947	0.00367	CcSEcCtD
Fosphenytoin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000903	0.0035	CcSEcCtD
Fosphenytoin—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000888	0.00345	CcSEcCtD
Fosphenytoin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000883	0.00343	CcSEcCtD
Fosphenytoin—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000861	0.00334	CcSEcCtD
Fosphenytoin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000848	0.00329	CcSEcCtD
Fosphenytoin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00326	CcSEcCtD
Fosphenytoin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.000839	0.00326	CcSEcCtD
Fosphenytoin—Chills—Riluzole—amyotrophic lateral sclerosis	0.000759	0.00294	CcSEcCtD
Fosphenytoin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000725	0.00281	CcSEcCtD
Fosphenytoin—Tension—Riluzole—amyotrophic lateral sclerosis	0.000722	0.0028	CcSEcCtD
Fosphenytoin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000721	0.0028	CcSEcCtD
Fosphenytoin—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000715	0.00277	CcSEcCtD
Fosphenytoin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000712	0.00276	CcSEcCtD
Fosphenytoin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000708	0.00274	CcSEcCtD
Fosphenytoin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00267	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000683	0.00265	CcSEcCtD
Fosphenytoin—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.00068	0.00264	CcSEcCtD
Fosphenytoin—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000676	0.00262	CcSEcCtD
Fosphenytoin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000664	0.00257	CcSEcCtD
Fosphenytoin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000661	0.00257	CcSEcCtD
Fosphenytoin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00256	CcSEcCtD
Fosphenytoin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000659	0.00256	CcSEcCtD
Fosphenytoin—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00252	CcSEcCtD
Fosphenytoin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000647	0.00251	CcSEcCtD
Fosphenytoin—Cough—Riluzole—amyotrophic lateral sclerosis	0.000642	0.00249	CcSEcCtD
Fosphenytoin—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000638	0.00247	CcSEcCtD
Fosphenytoin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00246	CcSEcCtD
Fosphenytoin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000627	0.00243	CcSEcCtD
Fosphenytoin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.000627	0.00243	CcSEcCtD
Fosphenytoin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000619	0.0024	CcSEcCtD
Fosphenytoin—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000613	0.00238	CcSEcCtD
Fosphenytoin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000606	0.00235	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000601	0.00233	CcSEcCtD
Fosphenytoin—Infection—Riluzole—amyotrophic lateral sclerosis	0.000597	0.00231	CcSEcCtD
Fosphenytoin—Shock—Riluzole—amyotrophic lateral sclerosis	0.000591	0.00229	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000588	0.00228	CcSEcCtD
Fosphenytoin—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.000586	0.00227	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000581	0.00225	CcSEcCtD
Fosphenytoin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000573	0.00222	CcSEcCtD
Fosphenytoin—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000561	0.00218	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000547	0.00212	CcSEcCtD
Fosphenytoin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000543	0.00211	CcSEcCtD
Fosphenytoin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000539	0.00209	CcSEcCtD
Fosphenytoin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000535	0.00208	CcSEcCtD
Fosphenytoin—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000534	0.00207	CcSEcCtD
Fosphenytoin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000529	0.00205	CcSEcCtD
Fosphenytoin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000522	0.00203	CcSEcCtD
Fosphenytoin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000514	0.00199	CcSEcCtD
Fosphenytoin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000495	0.00192	CcSEcCtD
Fosphenytoin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000477	0.00185	CcSEcCtD
Fosphenytoin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000475	0.00184	CcSEcCtD
Fosphenytoin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000431	0.00167	CcSEcCtD
Fosphenytoin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000425	0.00165	CcSEcCtD
Fosphenytoin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00159	CcSEcCtD
Fosphenytoin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00154	CcSEcCtD
Fosphenytoin—Phenylbutazone—PTGS2—amyotrophic lateral sclerosis	0.000392	0.146	CrCbGaD
Fosphenytoin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000382	0.00148	CcSEcCtD
Fosphenytoin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000379	0.00147	CcSEcCtD
Fosphenytoin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000378	0.00147	CcSEcCtD
Fosphenytoin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000376	0.00146	CcSEcCtD
Fosphenytoin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000357	0.00138	CcSEcCtD
